NCT04970121View on ClinicalTrials.gov

Efficacy and Safety of Duloxetine in Chinese Solid Tumor Patients with Taxanes-induced Painful Peripheral Neuropathy

PHASE2RecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

August 21, 2021

Primary Completion Date

July 1, 2025

Study Completion Date

December 1, 2025

Conditions

Chemotherapy-induced Peripheral NeuropathyPainSolid Tumor

Interventions

DRUG

Duloxetine

"Duloxetine, tablets, 20mg as starting dose and up to 60mg as maximum dose, once daily.~Taxanes is used according to manual instruction and patient condition."

Trial Locations (1)

233004

RECRUITING

Jing Liu, Bengbu

All Listed Sponsors

lead

Yan Yang, MD, Ph.D

OTHER